Swiss president heads for damage-control EU summit
Send a link to a friend
[April 22, 2021]
By Michael Shields
ZURICH (Reuters) - Swiss President Guy
Parmelin heads to Brussels on Friday for a summit with European
Commission President Ursula von der Leyen over a stalled treaty that
threatens to put ties between Switzerland and its biggest trading
partner into a deep freeze.
Many Swiss business leaders who are keen on continued smooth access to
the EU market want a treaty, but political resistance to the agreement
gives Parmelin little leeway to clinch a deal after years of
foot-dragging in Bern.
That could leave Parmelin, a member of the eurosceptic Swiss People's
Party, the biggest in parliament, in damage-control mode when he meets
von der Leyen, who has urged Bern finally to embrace the draft accord
negotiated in 2018.
The Swiss cabinet has said it wants clarifications on some open points
before endorsing the pact, and officials in Brussels want concrete
suggestions from Parmelin, one source familiar with the talks said.
Parmelin said in a weekend newspaper interview he would seek to move the
discussion forward without bombast.
[to top of second column]
|
Guy Parmelin President of the Swiss Confederation attends a news
conference on the outbreak of the coronavirus disease (COVID-19) in
Bern, Switzerland, March 12, 2021. REUTERS/Denis Balibouse
"I am not going to play Boris Johnson," he said,
referring to the British leader's blustering stance toward EU ties
during Britain's exit from the bloc.
The treaty would have non-EU member Switzerland routinely adopt
single market rules and provide a more effective way to resolve
disputes. Critics say it infringes Swiss sovereignty so much that it
would never survive a binding referendum. [L8N2MD5I1]
Failure to strike a deal would leave in place a patchwork of
sectoral accords that govern bilateral ties, but block Switzerland
from any new access to the single market, dashing plans for an
electricity union, for example.
Even the existing accords will erode over time. A deal that eases
cross-border trade in medical technology products lapses in May, for
instance, and Swiss scientists worry they may be frozen out of the
EU's Horizon research programme.
(Reporting by Michael Shields; Editing by Angus MacSwan)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |